Thus, many of the featured studies seek to overcome ... Integrative Cancer Research at the Massachusetts Institute of Technology (MIT), told The American Journal of Managed Care ® in an interview ...

An expert sat down to discuss the emotional and physical barriers patients may face when seeking support for fear of cancer progression. Emotional barriers patients face when communicating with their ...

For those of us who have been in the field for decades, this cycle of exhilaration or despair is common and manageable, but recent months have raised even further uncertainty about how progress in ...

ImmunoGenesis, a clinical-stage biotechnology company developing innovative, science-driven immune therapies, and Cancer ...

The National Comprehensive Cancer Network hosted an Oncology Policy Summit in Washington, D.C., today, focused on improving ...

The capacity to incorporate real-time data has revolutionized patient care in the rapidly evolving field of healthcare ...

Antibody-drug conjugates combined with immunotherapy have redefined the standard of care for advanced bladder cancer, replacing single-agent ... But there might be other [predictive factors] that will ...

So, how can the hurdles to continued healthcare provider (HCP) and patient adoption be overcome in this saturated ... with their limited apps. Whilst standard PaaS (platform as a service ...

ensuring access to care and treatment, as well as needed education and resources as part of shared decision making. The Oncology Navigation Standards of Professional Practice include ...

Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapies, cancer genomics, using AI to personalize cancer treatment, improving diagnosis of hard-to-treat ...

The claims cover combination treatment of onvansertib + bev for all bev-naïve patients including RAS-mutated and RAS wild type mCRC across all lines of therapy through 2043SAN DIEGO, April 23, 2025 ...

New data presented at AACR supports adding pembrolizumab before and after surgery in patients with newly diagnosed locally ...